… The results of this meta-analysis confirm the benefit of maintenance erlotinib in patients
with advanced NSCLC who had not progressed after four cycles of induction (platinum-based) …

… Discussion regarding the optimal duration of RTX maintenance therapy should also include
… a pooled analysis of all FVSG randomised controlled trials on RTX maintenance therapy in …

… We present the results of a pooled analysis of two 18month, … This analysis allows a more
highly powered assessment of the … A pooled analysis also permits investigation of key subsid…

… Nevertheless, whether therapy should be continued in patients achieving CR remains an …
, this pooled analysis is the first study to investigate the effect of a maintenance therapy in MM …

… In conclusion, this pooled analysis including four phase II RCTs supports the recent guideline
recommendation to maintenance with fluoropyrimidine plus anti-EGFR after an oxaliplatin- …

… , while delivering a high percentage of the planned dose of maintenance drugs. The phase
III trials included in this analysis did meet such requirements, and CT successfully translated …

… , administered every 4 or 8 weeks, was similar to daily 3-drug oral therapy of CAB plus …
pooled analyses of the efficacy (noninferiority), viral resistance, pharmacokinetic analysis, …

… pooled analysis investigated the efficacy and safety of umeclidinium/vilanterol (UMEC/VI)
62.5/25 mcg/day compared with tiotropium (TIO) 18 mcg/day in a maintenance-… in this analysis. …

… a pooled analysis of two phase III trials, RV-MM-EMN-441 and EMN01, to compare maintenance
with … A secondary aim was to evaluate the impact of duration of maintenance on overall …

… Because inadequate sample size was anticipated for all four maintenance trials, a pooled
analysis was intended at the outset. There was a significant overall difference among …